Poster Session Highlights BRD Research

First Place: Veronica Munoz, West Texas A&M: Comparative Efficacy of Metaphylaxis with Tulathromycin and Pentavalent Modified-Live Virus Vaccine in High-Risk, Newly Received Feedlot Cattle.
First Place: Veronica Munoz, West Texas A&M: Comparative Efficacy of Metaphylaxis with Tulathromycin and Pentavalent Modified-Live Virus Vaccine in High-Risk, Newly Received Feedlot Cattle.
(John Maday)

Editor’s note: We’ll have a series of articles summarizing highlights from the recent Bovine Respiratory Disease Symposium and Academy of Veterinary Consultants Conference on this site over the rest of this month. Check back often.

Along with presentations covering multiple aspects of bovine respiratory disease (BRD), the recent BRC symposium in Denver featured a poster session, where graduate students and their advisors exhibited cutting-edge research into prevention, detection and control of the BRD complex.

A panel of expert judges graded the 12 poster presentations, and announced awards for the top three at the end of the conference.

First Place: Veronica Munoz, West Texas A&M: Comparative Efficacy of Metaphylaxis with Tulathromycin and Pentavalent Modified-Live Virus Vaccine in High-Risk, Newly Received Feedlot Cattle.

Munoz and her team assigned 480 five-weight steer and bull calves to four treatment groups:

  • No metaphylaxis or MLV vaccine on arrival.
  • Metaphylaxis administration upon arrival
  • MLV vaccine administered on arrival and 14 days later.
  • Metaphylaxis and MLV vaccine on arrival and revaccination at day 14.

In this trial, researchers found that on-arrival metaphylaxis with Tulathromycin improved health and performance of high-risk calves, but on-arrival MLV vaccination with revaccination on day 14 did not.

Second Place: Matt Scott, Mississippi State University: Whole-Blood RNS-Seq Analysis of Stocker Calves at Arrival Provides Immunological and Metabolic Distinction Related to BRD.

Third Place: Emily Snyder, University of Georgia: Systematic Review and Meta-Analysis Comparing Arrival Versus Delayed Vaccination of High-Risk Beef Cattle with 5-Way Modified-Live Vaccines Against BHV-1, BRSV, PI3 and BVD Types 1 and 2.

 

Latest News

Properly Prepared Beef Remains Safe; Meat Institute Calls For Guidance to Protect Workers at Beef Facilities
Properly Prepared Beef Remains Safe; Meat Institute Calls For Guidance to Protect Workers at Beef Facilities

The Meat Institute said properly prepared beef remains safe to eat and called for USDA and the CDC to provide worker safety guidance specific to beef processors to ensure workers are protected from infection.

 A Message to the Ag Industry about H5N1
A Message to the Ag Industry about H5N1

The livestock industry needs a comprehensive, cohesive plan to address the virus. Producers, their employees and veterinarians need clear answers and support from U.S. agricultural leadership, moving forward.

USDA Now Requiring Mandatory Testing and Reporting of HPAI in Dairy Cattle as New Data Suggests Virus Outbreak is More Widespread
USDA Now Requiring Mandatory Testing and Reporting of HPAI in Dairy Cattle as New Data Suggests Virus Outbreak is More Widespread

USDA is now ordering all dairy cattle must be tested prior to interstate travel as a way to help stop the spread of HPAI H5N1. This comes a day after FDA confirmed virus genetic material was found in retail milk samples.

Mistrial Declared in Arizona Rancher’s Murder Trial
Mistrial Declared in Arizona Rancher’s Murder Trial

A lone juror stood between rancher George Kelly and innocent. “It is what it is, and it will be what it will be. Let me go home, okay?”

USDA Shares Recent H5N1 Avian Flu Sequences
USDA Shares Recent H5N1 Avian Flu Sequences

APHIS announced it has shared 239 genetic sequences of the H5N1 avian flu virus which will help scientists look for new clues about the spread of the virus.

Fairlife Breaks Ground on $650 Million Facility in New York
Fairlife Breaks Ground on $650 Million Facility in New York

Fairlife is known for its value-added dairy products, such as ultra-filtered milk, protein shakes and lactose-free milk. Soon, the company will be producing these popular products at its upcoming facility in N.Y.